Focusing on the initiation of treatment for newly diagnosed patients with CML, Jorge E. Cortes, MD, details important factors to consider when starting treatment and Claire Saxton discusses strategies that optimize communication when considering treatment options.
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions: